These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 29429592

  • 1. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y, Wu T, Wang Y, Yang L, Hu C, Chen L, Wu S.
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [Abstract] [Full Text] [Related]

  • 2. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH, Yang J, Gao LK, Min J, Tang JM, Hu M, Li Y, Li ST, Chen J, Hong L.
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [Abstract] [Full Text] [Related]

  • 3. γ-Glutamyl cyclotransferase contributes to endometrial carcinoma malignant progression and upregulation of PD-L1 expression during activation of epithelial-mesenchymal transition.
    Xu S, Yang Y, Wang X, Liu X, Jin C, Ma M, Wu S, Li Y.
    Int Immunopharmacol; 2020 Apr; 81():106039. PubMed ID: 31757677
    [Abstract] [Full Text] [Related]

  • 4. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S, Gonugunta VK, Penugurti V, Malisetty VL, Vadlamudi RK, Manavathi B.
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [Abstract] [Full Text] [Related]

  • 5. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z.
    Oncotarget; 2016 Apr 05; 7(14):18247-61. PubMed ID: 26919096
    [Abstract] [Full Text] [Related]

  • 6. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J.
    J Exp Clin Cancer Res; 2018 Dec 05; 37(1):304. PubMed ID: 30518405
    [Abstract] [Full Text] [Related]

  • 7. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H, Zhu D, Zheng Z, Cai Y, Chen Z, Xie W.
    Clin Transl Oncol; 2019 Jul 05; 21(7):939-949. PubMed ID: 30607788
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression.
    Deng J, Bai X, Feng X, Ni J, Beretov J, Graham P, Li Y.
    BMC Cancer; 2019 Jun 24; 19(1):618. PubMed ID: 31234823
    [Abstract] [Full Text] [Related]

  • 9. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.
    Zi D, Zhou ZW, Yang YJ, Huang L, Zhou ZL, He SM, He ZX, Zhou SF.
    Int J Mol Sci; 2015 Nov 13; 16(11):27228-51. PubMed ID: 26580601
    [Abstract] [Full Text] [Related]

  • 10. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
    Li J, Feng L, Tian C, Tang YL, Tang Y, Hu FQ.
    Eur Rev Med Pharmacol Sci; 2018 Dec 13; 22(23):8135-8144. PubMed ID: 30556851
    [Abstract] [Full Text] [Related]

  • 11. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
    Liu L, Wu N, Wang Y, Zhang X, Xia B, Tang J, Cai J, Zhao Z, Liao Q, Wang J.
    J Exp Clin Cancer Res; 2019 Feb 28; 38(1):106. PubMed ID: 30819230
    [Abstract] [Full Text] [Related]

  • 12. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
    Yang Y, Zhang J, Zhu Y, Zhang Z, Sun H, Feng Y.
    Int J Gynecol Cancer; 2014 Nov 28; 24(9):1564-74. PubMed ID: 25340291
    [Abstract] [Full Text] [Related]

  • 13. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
    Baek SH, Ko JH, Lee JH, Kim C, Lee H, Nam D, Lee J, Lee SG, Yang WM, Um JY, Sethi G, Ahn KS.
    J Cell Physiol; 2017 Feb 28; 232(2):346-354. PubMed ID: 27177359
    [Abstract] [Full Text] [Related]

  • 14. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.
    Liang Z, Ge Y, Li J, Bai Y, Xiao Z, Yan R, An G, Zhang D.
    J Cancer Res Clin Oncol; 2024 Jul 09; 150(7):342. PubMed ID: 38980538
    [Abstract] [Full Text] [Related]

  • 15. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L, Liao Q, Zou Z, Wen Y, Wang J, Liu C, He Q, Weng N, Zeng J, Tang H, Fang R, Lei Z, Tang Z, Yang X, Cui S.
    Cell Physiol Biochem; 2018 Jul 09; 51(3):1221-1236. PubMed ID: 30481766
    [Abstract] [Full Text] [Related]

  • 16. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
    Li X, Teng S, Zhang Y, Zhang W, Zhang X, Xu K, Yao H, Yao J, Wang H, Liang X, Hu Z.
    Oncotarget; 2017 Jul 18; 8(29):47052-47063. PubMed ID: 28423362
    [Abstract] [Full Text] [Related]

  • 17. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H, Zhang C, Xu L, Zang K, Ning Z, Jiang F, Chi H, Zhu X, Meng Z.
    Oncotarget; 2016 Apr 12; 7(15):20193-208. PubMed ID: 26958938
    [Abstract] [Full Text] [Related]

  • 18. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J, Zhao X, Jiang H, Yang T, Li D, Yang X, Jia A, Ma Y, Qian Z.
    Tissue Cell; 2022 Aug 12; 77():101817. PubMed ID: 35679685
    [Abstract] [Full Text] [Related]

  • 19. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J, Cozzi P, Hao J, Beretov J, Chang L, Duan W, Shigdar S, Delprado W, Graham P, Bucci J, Kearsley J, Li Y.
    Int J Biochem Cell Biol; 2013 Dec 12; 45(12):2736-48. PubMed ID: 24076216
    [Abstract] [Full Text] [Related]

  • 20. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J, Huang J, Xu J, Huang Q, Wang J, Zhong W, Lin X, Li Y, Lin X.
    BMC Cancer; 2017 Sep 06; 17(1):626. PubMed ID: 28874138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.